SELECT THE RIGHT TEST FOR YOU
With VERACITY and VERAgene, you have the option of taking a highly accurate (>99%) and safe non-invasive prenatal test (NIPT) to check for genetic conditions of the fetus before birth with no risk for miscarriage. In both NIPTs, cell-free DNA from the mother’s blood is analyzed to detect potential changes in the genome including aneuploidies and microdeletions. Additionally, VERAgene tests for single gene (monogenic) disorders in the biological parents. Both tests are recommended for any pregnant women, independent of age and risk category and can be done from 10th week of pregnancy. Choose VERACITY to detect the most common fetal aneuploidies and microdeletions which occur more frequent with advanced maternal age. Choose VERAgene if you additionally want to simultaneously screen for other microdeletions and monogenic diseases that do not have any maternal age-associated risk and can have a significant impact on life quality. The outcome of the test can help parents take informed decisions about possible treatments and clinical management.
VERACITY
Detection of the most common fetal aneuploidies and microdeletions (all included in VERAgene as well) which occur more frequent with advanced maternal age. VERACITY has been validated by several clinical studies for single and twin pregnancies, and can also be used in pregnancies conceived through in-vitro fertilization (IVF).
VERAgene
Simultaneous screen for aneuploidies (included in VERACITY), microdeletions and monogenic diseases provides a comprehensive solution to prospective parents using a single test. Genetic diseases screened in VERAgene are associated with significant impact on life quality.
Rhesus factor test
LATEST ARTICLES
A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti…
Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati…
Cardiovascular diseases affect the heart and blood vessels and are a leading cause of illness and death. Some are hereditary, and genetic testing can…
A recent study tracked molecular changes in 108 people over time, revealing that aging involves critical shifts around ages 44 and 60. These changes …
In May 2024, the American Society of Clinical Oncology (ASCO) published new guidelines for germline genetic testing in patients with cancer (1). …
Genetics as we know and understand it today has been shaped, over decades, by the work of many dedicated scientists around the world, and they all de…
A comprehensive single-cell transcriptomic atlas of 1.3 million cells from aged human brains reveals cellular pathways linked to Alzheimer’s diseas…
Infertility is a struggle for many individuals nowadays. According to the World Health Organization (WHO), 1 in 6 people experience infertility, show…
A recent study highlights promising outcomes for BRCA variant carriers with breast cancer undergoing breast-conserving therapy. Analyzing 172 women, …
Epidermolysis bullosa (EB), sometimes called butterfly skin, is a group of rare skin diseases with a common symptom: fragile skin that tears and blis…
